Exosome RNA Exosome RNA Research & Industry News
Liquid biopsy is a new, minimally invasive technology for detection of disease biomarkers without the need for costly or invasive procedures. In this video, Dr. Brian Adams talks about the role of miRNA from exosomes as potential circulating biomarkers, challenges and recommended techniques for isolating these tiny microvesicles. Liquid biopsies promise to revolutionize the way serious diseases are detected and monitored.
Don't Miss
- Extracellular vesicles released following exercise in healthy men could indicate muscle damage
- Single EV analysis (sEVA) of mutated proteins allows early detection of pancreatic cancer
- Spartina Biotechnologies raises money for exosome technology designed to impede Covid-19 and other viruses
- Extracellular vesicles synchronize cellular phenotypes of differentiating cells
- Featured Exosome Job – Research Scientist – Extracellular Vesicle and Cancer Nanotechnology
- Exosomes & EVs – Isolation, Characterization, Machine Learning for RNA diagnostics
- Personal Genome Diagnostics and Cleveland Clinic Collaborate to Expand Utility of Liquid Biopsy Applications in Oncology Clinical Research
- Engineering exosome polymer hybrids by atom transfer radical polymerization
- Researchers developing stable cell line for production of exosomes for vaccine development
- Penn Medicine and Wistar awarded $11.7 million to study exosomes and immunotherapy in melanoma
